Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: Promising activity of quinolones and rifamycins

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 76-79

  Klein, Marina B ^a   Nelson, Curtis M ^a   Goodman, Jesse L ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; OFLOXACIN; QUINOLONE DERIVATIVE; RIFAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; DRUG ACTIVITY; DRUG EFFICACY; EHRLICHIOSIS; GRANULOCYTE; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SEROLOGY; TICK BORNE DISEASE;

EID: 0031019283     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.76     Document Type: Article

References (22)

1. Bakken, J. S., J. Kreuth, C. Wilson-Nordskog, R. L. Tilden, K. Asanovitch, and J. S. Dumler. 1996. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275:199-205.
2. Bakken, J. S., J. S. Dumler, S.-M. Chen, M. R. Eckman, L. L. Van Etta, and D. H. Walker. 1994. Human granulocytic ehrlichiosis in the upper Midwest United States. JAMA 272:212-218.
3. Brouqui, P., and D. Raoult. 1992. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans. Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 36:2799-2803.
4. Brouqui, P., and D. Raoult. 1993. Susceptibilities of ehrlichiae to antibiotics, p. 181-198. In D. Raoult (ed.), Antimicrobial agents and intracellular pathogens. CRC Press, Inc., Boca Raton, Fla.
5. Brouqui, P., and D. Raoult. 1990. In vitro susceptibility of Ehrlichia sennetsu to antibiotics. Antimicrob. Agents Chemother. 34:1593-1596.
6. Centers for Disease Control and Prevention. 1995. Human granulocytic ehrlichiosis - New York, 1995. Morbid. Mortal. Weekly Rep. 44:593-595.
7. Chen, S.-M., J. S. Dumler, J. S. Bakken, and D. H. Walker. 1994. Identification of a granulocytic ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32:589-595.
8. Dumler, J. S., K. M. Asanovich, J. S. Bakken, P. Richter, R. Kimsey, and J. E. Madigan. 1995. Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic ehrlichia. J. Clin. Microbiol. 33:1098-1103.
9. Fishbein, D. B., J. E. Dawson, and L. E. Robinson. 1994. Human ehrlichiosis in the United States, 1985 to 1990. Ann. Intern. Med. 120:736-743.
10. Goodman, J. L., C. Nelson, B. Vitale, J. E. Madigan, J. S. Dumler, T. J. Kurtti, and U. G. Munderloh. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334:209-215.
11. Harkess, J. R., S. A. Ewing, T. Brumit, and C. R. Mettry. 1991. Ehrlichiosis in children. Pediatrics 87:199-203.
12. Ijdo, J. W., E. Hodzic, P. Webster, S. Barthold, E. Fikrig, and S. R. Telford. 1996. A murine model for human granulocytic ehrlichiosis: characterization of cardiac and hematologie disease and the immune response to infection. In Twelfth Sesqui-annual Meeting of the American Society for Rickettsiology and Rickettsial Diseases, Asiloma, Calif.
13. Jacobs, R. F., and C. B. Wilson. 1983. Intracellular penetration and antimicrobial activity of antibiotics. J. Antimicrob. Chemother. 12(Suppl. C):13-20.
14. Krause, P. J., S. R. Telford, A. Spielman, et al. 1996. Concurrent Lyme disease and babesiosis. JAMA 275:1657-1660.
15. Kubin, R. 1993. Safety and efficacy of ciprofloxacin in pediatric patients -review. Infection 21:413-421.
16. Magnarelli, L. A., J. S. Dumler, J. F. Anderson, R. C. Johnson, and E. Fikrig. 1995. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J. Clin. Microbiol. 33:3054-3057.
17. Neu, H. C., and N.-X. Chin. 1994. In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob. Agents Chemother. 38:2615-2622.
18. Panchioli, P., C. P. Kolbert, P. D. Mitchell, et al. 1995. Ixodes damini as a potential vector of human granulocytic ehrlichiosis. J. Infect. Dis. 172:1007-1012.
19. Prokesch, R. C., and W. L. Hand. 1982. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 21:373-380.
20. Schaad, U. B., M. A. Salam, Y. Aujard, et al. 1995. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr. Infect. Dis. J. 14:1-9.
21. Telford, S. R., T. J. Lepore, P. Snow, C. K. Warner, and J. E. Dawson. 1995. Human granulocytic ehrlichiosis in Massachusetts. Ann. Intern. Med. 123: 277-279.
22. Woods, G. L., and J. A. Washington. 1995. Antibacterial susceptibility tests: dilution and disk diffusion methods, p. 1327-1341. In E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.